Cigna Corporation
HealthcareNYSE:CI · New York Stock Exchange
+$3.24 today
Vol 0.53M · Avg 1.65M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $7.0B |
| Short-term Investments | $812.0M |
| Receivables | $26.6B |
| Inventory | $5.8B |
| Other Current | $2.7B |
| Total Current Assets | $43.0B |
| PP&E (Net) | $3.7B |
| Goodwill | $45.5B |
| Intangible Assets | $27.3B |
| Long-term Investments | $18.9B |
| Other Non-current | $14.8B |
| Total Non-current Assets | $110.2B |
| Total Assets | $153.3B |
Analysis
Selected assets total $153.3B for Latest. The largest visible component is Goodwill at $45.5B, about 29.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.7B +1.7% | $7.5B -3.5% | $7.8B +32.0% | $5.9B +16.6% | $5.1B | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 -100.0% | $665.0M -28.1% | $925.0M +2.2% | $905.0M -1.6% | $920.0M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $28.8B +19.5% | $24.1B +37.9% | $17.4B +2.8% | $17.0B +16.1% | $14.6B | $533.8M | $399.4M | -$1.7B |
| Inventory | $7.3B +9.7% | $6.7B +18.5% | $5.6B +18.2% | $4.8B +28.3% | $3.7B | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $4.0B -59.3% | $9.9B +79.7% | $5.5B +256.3% | $1.5B -86.9% | $11.8B | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $47.8B -2.2% | $48.9B +30.8% | $37.4B +24.0% | $30.1B -16.6% | $36.1B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $3.7B +340.9% | $828.0M -5.6% | $877.0M -32.6% | $1.3B -21.8% | $1.7B | $1.2B | $1.5B | $687.8M |
| Goodwill | $44.9B +1.2% | $44.4B +0.3% | $44.3B -3.4% | $45.8B +0.0% | $45.8B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $28.6B -11.4% | $32.2B -4.3% | $33.7B -4.7% | $35.3B -4.3% | $36.9B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $18.5B +22.1% | $15.1B -15.9% | $18.0B +10.8% | $16.2B -11.7% | $18.4B | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $14.5B +0.4% | $14.4B -22.4% | $18.6B +23.4% | $15.1B -5.6% | $16.0B | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $110.1B +2.9% | $107.0B -7.3% | $115.4B +1.4% | $113.8B -4.2% | $118.8B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $157.9B +1.3% | $155.9B +2.0% | $152.8B +6.2% | $143.9B -7.1% | $154.9B | $13.3B | $11.9B | $10.6B |
| Account Payables | $10.7B -71.8% | $37.8B +33.1% | $28.4B +14.2% | $24.8B +13.1% | $22.0B | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $592.0M -80.2% | $3.0B +9.5% | $2.7B -7.7% | $3.0B +17.4% | $2.5B | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $45.1B +321.5% | $10.7B +9.9% | $9.7B +79.9% | $5.4B -53.9% | $11.7B | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $56.3B -2.8% | $58.0B +19.0% | $48.7B +18.2% | $41.2B -5.4% | $43.6B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $30.9B +6.8% | $28.9B +2.9% | $28.1B +0.2% | $28.0B -9.8% | $31.1B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $7.1B +2.4% | $7.0B -2.8% | $7.2B | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $21.7B +4.5% | $20.7B -7.2% | $22.4B -24.1% | $29.5B -9.6% | $32.6B | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $59.7B +5.4% | $56.7B -1.8% | $57.7B -0.4% | $57.9B -9.7% | $64.1B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $116.0B +1.2% | $114.6B +7.7% | $106.4B +7.5% | $99.0B -8.1% | $107.7B | $14.7B | $3.7B | $9.6B |
| Common Stock | $4.0M +0.0% | $4.0M +0.0% | $4.0M +0.0% | $4.0M +0.0% | $4.0M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $47.9B +10.0% | $43.5B +4.5% | $41.7B +10.0% | $37.9B +16.2% | $32.6B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$2.8B -19.9% | -$2.3B -25.6% | -$1.9B -33.6% | -$1.4B -57.8% | -$884.0M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $161.0M -23.3% | $210.0M +64.1% | $128.0M +62.0% | $79.0M +9.7% | $72.0M | $1.4B | $337.8M | $931.4M |
| Total Equity | $41.9B +1.5% | $41.2B -11.0% | $46.4B +3.1% | $45.0B -4.7% | $47.2B | $9.1B | $7.7B | $3.3B |
| Total Debt | $31.5B -1.6% | $32.0B +3.4% | $30.9B -2.0% | $31.6B -7.9% | $34.3B | $724.2M | $410.6M | $399.4M |
| Net Debt | $23.8B -2.6% | $24.4B +5.7% | $23.1B -9.8% | $25.6B -12.2% | $29.2B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
CVS Health Corporation
NYSE:CVS
$129.94B
Elevance Health Inc.
NYSE:ELV
$87.39B
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
$63.35B
Cencora, Inc.
NYSE:COR
$54.86B
Becton, Dickinson and Company
NYSE:BDX
$52.82B
Cardinal Health, Inc.
NYSE:CAH
$52.49B
Humana Inc.
NYSE:HUM
$45.41B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.09B
Zoetis Inc.
NYSE:ZTS
$33.61B
Centene Corporation
NYSE:CNC
$32.41B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does CI have?
Cigna Corporation (CI) reported $7.68B in cash and equivalents in fiscal 2025.
How much debt does CI carry?
Cigna Corporation (CI) reported $31.46B of total debt, with net debt of $23.79B.
Explore More
Continue the stock analysis
Jump to another research area for this company.